Eyenovia

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eyenovia and other ETFs, options, and stocks.

About EYEN

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes.

CEO

Michael M. Rowe

CEOMichael M. Rowe

Employees

Employees45

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2014

Founded2014

Employees

Employees45

EYEN Key Statistics

Market cap

66.81M

Market cap66.81M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

180.45K

Average volume180.45K

High today

$1.90

High today$1.90

Low today

$1.78

Low today$1.78

Open price

$1.86

Open price$1.86

Volume

48.10K

Volume48.10K

52 Week high

$4.21

52 Week high$4.21

52 Week low

$1.52

52 Week low$1.52

EYEN Earnings

-$0.24

-$0.13

-$0.01

$0.10

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 27, After Hours

ActualExpected Mar 27, After Hours

Eyenovia

Why Robinhood?

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Show more

EYEN Key Statistics

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes.